戻る
Uniqure NV (QURE)価格
QURE 株価推移チャート
QURE 収入
Uniqure NV
$22.37
-7.21%
$-1.73
終値： Feb 12, 16:00:00 GMT-5
$22.9
2.36%
$0.52
アフターマーケット：Feb 12, 20:00:00 GMT-5
C-
最終スコア
主要データ
前終値
$24.11
始値
$23.97
当日レンジ
$22.29 - $24.39
52週レンジ
$7.76 - $71.5
取引高
1.8M
平均取引高
2.2M
1株当たり利益(TTM)
-4.39
配当利回り
--
時価総額
$1.4B
QUREとは何ですか？
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. The company is headquartered in Amsterdam, Noord-Holland and currently employs 209 full-time employees. The company went IPO on 2014-02-05. The company seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. The company develops, both internally and through partnerships, a pipeline of gene therapies. The company produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.